NCT02958098 is a clinical trial in Myocardial Infarction, sponsored by American Heart Association.

Who is sponsoring NCT02958098?

NCT02958098 is sponsored by American Heart Association.

What condition does NCT02958098 study?

NCT02958098 studies Myocardial Infarction, Stroke, Cardiomyopathy, Dilated, Systolic Heart Failure, Atrial Fibrillation, Aortic Dissection.

Is NCT02958098 still recruiting?

NCT02958098 is currently terminated. Last updated 8 March 2021.

Last reviewed 2021-03-08 · How we verify

NCT02958098

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

My Research Legacy Pilot Study

Terminated Last updated 8 March 2021

What this trial tests

trial in Myocardial Infarction in 2,267 participants. Terminated before completion.

Timeline

11 November 2016

Primary endpoint
30 October 2018

30 October 2018

Quick facts

Lead sponsor	American Heart Association
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	2,267
Start date	11 November 2016
Primary completion	30 October 2018
Estimated completion	30 October 2018

Conditions studied

Myocardial Infarction — all drugs for Myocardial Infarction →
Stroke — all drugs for Stroke →
Cardiomyopathy, Dilated — all drugs for Cardiomyopathy, Dilated →
Systolic Heart Failure — all drugs for Systolic Heart Failure →

Sponsor

American Heart Association

Who can join

Adults 18 to 89, any sex, with Myocardial Infarction or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The My Research Legacy Pilot Study will establish a participant registry that collects self-reported health data and answers to online survey questions about individual daily choices, diets, and exercise; data from wearable devices; and, (optional) data from genome sequencing analysis. Individuals under the age of 50 who meet eligibility criteria will answer questions using the American Heart Association's (AHA) Life's Simple 7™ My Life Check v4.0 three times over the course of 6 months and transmit data from a Fitbit Charge 2 device. All other individuals who are interested in the study and meet entry criteria may also enroll.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

A precision medicine approach to sex-based differences in ideal cardiovascular health.
Leopold JA, Antman EM. · · 2021 · cited 5× · PMID 34290276 · DOI 10.1038/s41598-021-93966-3
Data from Digital Health Devices Informs Ideal Cardiovascular Health.
Leopold JA, Davis RB, Antman EM. · · 2021 · cited 4× · PMID 33801949 · DOI 10.3390/jpm11030189
Digital health device measured sleep duration and ideal cardiovascular health: an observational study.
Leopold JA, Antman EM. · · 2021 · cited 1× · PMID 34649522 · DOI 10.1186/s12872-021-02284-z

Verify or expand the search:

Other recruiting trials for Myocardial Infarction

Currently open trials in the same condition.

NCT07257198 — Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone · Phase 3 · recruiting
NCT07402642 — Effect of Early Educational Intervention on Cardiovascular Risk Factors After Acute Coronary Syndrome · NA · recruiting
NCT07301034 — A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, · Phase 3 · recruiting
NCT07142265 — Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients · recruiting
NCT07138911 — Effect of Home-based Exercise Plan Mediated by Use of Digital Health App on Kinesiophobia and Functional Capacity · NA · recruiting

Other American Heart Association trials

Trials by the same sponsor.

NCT06483165 — F.A.S.T.-BE FAST Stroke Warning Signs Study · NA · enrolling by invitation
NCT05130268 — Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation · Phase 4 · completed
NCT04425356 — Are Mindfulness Programs in the Workplace Effective at Reducing Stress · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02958098 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by American Heart Association
Last refreshed: 8 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02958098.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing